Russian Direct Investment Fund (RDIF) said on 9/2, the European Union (EU) has approved the application for the use of Sputnik V vaccine in Russia’s European region.
|Eventually Europe has accepted the Russian vaccine.|
The EU received an application from RDIF on January 29 and started the information disclosure process to the European Pharmaceutical Authority (EMA) through the rotational assessment procedure. If approved, the Sputnik V vaccine could be made available in the EU, which has so far licensed the three COVID-19 vaccines, Pfizer-BoNTech, Moderna and AstraZeneca.
Russian Deputy Foreign Minister Alexander Pankin said in an interview that Russia is in talks with about 50 countries on the supply of the Sputnik V vaccine against COVID-19, according to TASS.
“Safe and highly effective Sputnik V vaccine products are being used in Russia on a large scale and have been licensed for use in more than 20 countries. By mid-February, this list is likely to come,” he said. increase to 25. Vaccine supply negotiations are underway with about 50 countries. “
Mr. Pankin emphasized that Russia joined the global efforts to combat the COVID-19 pandemic from the very beginning by providing assistance to a number of individual countries and through cooperation with organizations. international.
“We are determined to step up this work and provide all the partners interested in our products in the field of vaccinations against the SARS-CoV-2 virus,” said Pankin.
The Russian Deputy Foreign Minister reiterated that Moscow is cooperating with the World Health Organization with the aim of putting the Sputnik V vaccine on the list of medical products to be used in emergencies.
“In this way, we foster cooperation in different ways, which, in my opinion, is the most effective tactic in the context of an ongoing pandemic. This is also related to the promotion of COVID- vaccines. 19 other Russia to the world market “, Mr. Pankin confirmed.
In August 2020, when President Vladimir Putin announced that Russia approved the world’s first COVID-19 vaccine – Sputnik V, there were many doubts from outside. But up to now, Sputnik V is considered one of the biggest scientific breakthroughs of Russia since the time of the Soviet Union.
Bloomberg News (USA) said that many countries are “lining up” to receive Sputnik V. Especially when a study published in the prestigious medical journal The Lancet on 2/2 showed that Sputnik V has signs. COVID-19 preventive results reached nearly 92%.
The Russian COVID-19 Sputnik V vaccine, which was initially skeptical of the West, has now become a worldwide favorite in the fight against the COVID-19 pandemic, according to Bloomberg.
In recent years, the race to prepare the COVID-19 vaccine has been considered as prominent geopolitics because governments have sought to escape the economic and social damage from the blockade to avoid the spread of the epidemic.
Ms. Oksana Antonenko at the consulting firm Control Risks (UK) evaluated: “With Sputnik V, Russia has proven its capacity to produce new products to meet the needs of the world”.
While vaccine manufacturers across the globe are struggling to meet the current supply and demand situation, Russia has committed to free COVID-19 vaccination for 146 million people.
AstraZeneca Vaccine suffers from a picture crisis
The vaccine of the Anglo-Swedish pharmaceutical company AstraZeneca has just had an image crisis after South Africa announced a suspension of use.
South Africa announced on February 7 that it will suspend the use of the AstraZeneca vaccine in its vaccination program after a study announced that the vaccine did not provide a significant effect against the risk of mild or moderate COVID-19. flask caused by the South African variant, symbol 501Y.V2.
But the UK vaccine was quickly supported by the world medical community.
|The AstraZeneca vaccine is supported by the West.|
Then, Mr. Edward Argar – senior health official of England on February 8 defended the COVID-19 vaccine developed by the British pharmaceutical company AstraZeneca in collaboration with the University of Oxford, in the context of There are doubts about the effectiveness of this vaccine, especially after South Africa decided to temporarily stop using it.
Argar said there is no evidence that the Astrazeneca vaccine is ineffective in preventing the SARS-CoV-2 virus, which leaves patients hospitalized or at risk of death.
The emergence of many new variants of the SARS-CoV-2 virus is causing many concerns that vaccines prepared with the original vaccine may not be effective against the new variants. Currently, scientists and public health experts are particularly concerned about variants in the UK, South Africa and Brazil as all three appear to be contagious.
The overall message from the World Health Organization (WHO) and others is: “Don’t panic”. The study in South Africa is small and tested the vaccine using a 4-week interval between the first and second dose, according to some global health officials. short, because there is evidence that vaccines will work better if this time period is longer.
UK Prime Minister Boris Johnson told reporters: “We think that both vaccines (from AstraZeneca and Pfizer – PV) that we currently use are effective, as I said, in preventing disease.” serious and fatal ”.
French Health Minister Olivier Veran is hoping that the AstraZeneca vaccine will help speed up vaccination programs that are lagging behind other rich countries. The AstraZeneca vaccine provides adequate protection against “nearly all variants” of the virus, he said.
But if the vaccines are not working as well as expected against the new variants that are spreading, the world could face a war against viruses much longer and costly than previously thought. .
The South African dominant variant has appeared in at least 40 other countries, including the US.